Organization WHO. Diabetes 2021. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
Shahraz S, Moghaddam SS, Azmin M, Peykari N, Yoosefi M, Mohebi F, Khatibzadeh S, Fateh SM, Djalalinia S, Modirian M, Mahmoudi N. Prevalence of diabetes and Prediabetes, and achievements in Diabetes Control in Iran; the results of the STEPS of 2016. Arch Iran Med. 2022;1(9):591.
Amini MR, Sanjari M, Mohajeri Tehrani MR, Nasli E, Yazdanpanah L, Mousavi Z, Forghan F, Valizadeh N, Gozashti MH, Afkhami-Ardekani M, Siavash M. Evaluation of foot self-care status and foot screening problems in patients with diabetes in Iran: a national multicenter study. BMC Endocr disorders. 2023;21(1):178.
Pérez Unanua MP, Alonso Fernández M, López Simarro F, Soriano Llora T, Peral Martínez I, Mancera Romero J, et al. Adherence to healthy lifestyle behaviors in patients with type 2 diabetes in Spain. Semergen. 2020;S1138–3593(20):30317–8.
Sadeghi D. Improving adherence to treatment in patients with diabetes: practical strategies. Endocrinol Diabetes Metabolism. 2024;7(4).
Araya EM, Gebrezgabiher HA, Tekulu GH, Alema NM, Getnet D, Gebru HT, Adamu BA. Medication non-adherence and associated factors among diabetic patients visiting general hospitals in the eastern zone of Tigrai, Northern Ethiopia. Patient Prefer Adherence. 2020;29:2071–83.
Burnier M. The role of adherence in patients with chronic diseases. Eur J Intern Med. 2024;1:119:1–5.
Sabaté E. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003.
Dehvan F, Baghi V, Lotfi A, Ghanei Gheshlagh R. Medication adherence inhibitors and facilitators in type 2 diabetic patients: an integrative review. Sci J Nurs Midwif Param Fac. 2018;3(1):1–17.
Lavis JN, Wilson MG, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Sys. 2009;7(1):S4.
Fretheim A, Munabi-Babigumira S, Oxman AD, Lavis JN, Lewin S. SUPPORT Tools for evidence-informed health Policymaking (STP). 6. Using research evidence to address how an option will be implemented. Health Res Policy Syst. 2009;7(1):S6.
Article PubMed PubMed Central Google Scholar
Ranganathan LN, Ramaratnam S. Zonisamide monotherapy for epilepsy [Protocol]. Cochrane database Syst reviews. 2007;4:CD006789.
Khalili Azar K, Mirzaei A, Babapour AR, Fathnezhad-Kazemi A. https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools
Motaghi S, Boogar IR, Moradi S, Asl NS. The effectiveness of cognitive behavioral stress management on health-related quality of life, diabetes management self-efficacy, and treatment adherence in type 2 diabetes. Iran J diabetes Obes. 2023;13.
Abroshan F, Hosseini SM, Sotodeha N, Sabahi P. A comparison of the effectiveness of rational emotive behavior therapy (REBT), and acceptance and commitment therapy (ACT) in improving self-care behaviors: (nutritional behaviors, physical activity, blood sugar control, foot care, and medication adherence of patients) in women with type 2 diabetes. Appl Family Therapy J. 2022;3(1):37–55.
Zamani N, Ahmadi Tabatabaei SV, Khanjani N, Fadakar Davarani MM. The effect of educational intervention based on the health belief model on medication adherence among patients with diabetes referred to a diabetes center in Zarand, Kerman. Health Dev J. 2017;1(2):97–109.
Rezai Asl H, Pishgooi SA, Alhani F. The effectiveness of Family-Centered Empowerment Model on the treatment adherence of patients with type II diabetes and heart disorder admitted to AJA Hospitals, during year 2015. Military Caring Sci. 2017;10(1):58–69.
Rahimi R, Ahadi H, Tajeri B, Khoshlahjeh SA. The effectiveness of acceptance and commitment therapy on perceived stress, chronic pain and treatment adherence in diabetic elderly. 2023;7:76–85.
Rahmani S, Mansoobifar M, Sirifi MR, Ashayeri H, Bermas H. Effectiveness of motivational interviewing based on the ability, information and motivation model on adherence to treatment and glycosylated hemoglobin in females with type 2 diabetes mellitus. Iran J diabetes Obes. 2022;20.
Roozbehani R, Fatemi AA, Zamani Z, Khedri B, Arefkia K, Kabusi M, Shafiei Z, Razavinasab SA, Ilaghinezhad Bardsiri T, Eshaghzadeh M, Hosseini Foladi S. Impact of short message system education on blood sugar control and treatment adherence in patients with Type 2 diabetes. Iran Rehabilitation J. 2022;10(4):549–60.
Miri Z, Rezaee N, Faghihi H, Navidian A. Effect of cognitive-behavioral training combined with motivational interviewing on treatment adherence and hemoglobin A1c in patients with diabetes and depressive symptoms. Medical-Surgical Nurs J. 2021;10(3):e120496. https://doi.org/10.5812/msnj.120496
Bahadori M, Mehrabizadeh Honarmand M, Asgary P, Ahadi H, Moradi L. Effectiveness of compassion-focused therapy in alexithymia, adaptive behavior, treatment adherence, and biological factors in patients with type 2 diabetes. Razavi Int J Med. 2021;1(2):42–7.
Jalali N, Taghavi Kojidi H, Badrfam R, Zandifar A. The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran. J Diabetes Metabolic Disorders. 2021;20:153–9.
Abdollahi S, Hatami M, Manesh FM, Askari P. The effectiveness of acceptance and commitment therapy on the self-care and adherence to treatment in patients with type 2 diabetes. Int Archives Health Sci. 2020;1(2):78–83.
Ahrari S, Mohammadpour A, Amouzeshi Z, Agha-Yousefi A. The relationship between cognitive appraisal and adherence to medical regimens in type 2 diabetic patients. J caring Sci. 2014;3(4):277.
PubMed PubMed Central Google Scholar
Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E. Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 2013;1(2):111–8.
Sadeghi D, Darvish A. Adherence to treatment among patients with type 2 diabetes: short communication. J Diabetes Metabolic Disorders. 2025;24:112.
Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metabolic Disorders. 2013;12:1–9.
Bilondi SS, Noghabi AD, Aalami H. The relationship between illness perception and medication adherence in patients with diabetes mellitus type II: illness perception and medication adherence. J Prev Med Hyg. 2021;62(4):E966.
Pazokian M, Beigmoradi S, Movafegh F, Akbarzadeh S. Correlation between social support and hope with medication adherence in type II diabetic patients. Arch Pharma Pract. 2020;11(1):130–5.
Khalili Azar K, Mirzaei A, Babapour AR, Fathnezhad-Kazemi A. The mediating effect of self-efficacy on the relationship between social support and medication adherence in adults with type 2 diabetes. SAGE Open Med. 2024;12:20503121231221446.
Article PubMed PubMed Central Google Scholar
Ranjbaran S, Shojaeizadeh D, Dehdari T, Yaseri M, Shakibazadeh E. Determinants of medication adherence among Iranian patients with type 2 diabetes: an application of health action process approach. Heliyon. 2020;1(6):7.
Sanati T, Vaezi A, Jambarsang S. Medication adherence status and its related factors among older adults in Yazd, Iran. Elder Health J. 2020;10(2):85–90.
Badrizadeh A, Jamaloi R, Khanzadeh M, Foroughi S, Saki M. Medication adherence and its related factors in patients with type 2 diabetes. Yafteh. 2021;23(2):1–10
Benrazavy L, Khalooei A. Medication adherence and its predictors in type 2 diabetic patients referring to urban primary health care centers in Kerman City, Southeastern Iran. Shiraz E-Medical J. 2019;31;20(7).
Avazeh M, Babaei N, Farhoudi S, Kalteh EA, Gholizadeh B. Medication adherence in the elderly with chronic diseases referring to academic medical centers of Ardabil, Iran in 2018. Jundishapur J Chronic Disease Care. 2019;8(4):e94232.
Jafarian-Amirkhizi A, Sarayani A, Gholami K, Taghizadeh-Ghehi M, Heidari K, Jafarzadeh-Kohneloo A, Morisky DE. Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran. J Diabetes Metabolic Disorders. 2018;31:17:165–72.
Ostadzadeh A, Ebrahimi A, Mozaffari M. Investigating the relationship between quality of life with adherence and history of treatment (drug therapy) without psychotherapy and demographic characteristics in patients with type 2 diabetes. J Fundamentals Mental Health. 2017;21(19special issue):273–9.
Dashtian M, Ardebili HE, Shirazi KK, Shahmoradi M, Azam K. Predicting factors affecting medication adherence and physical activity in patients with type-2 diabetes mellitus based on the theory of planned behavior. 2017;14(2):133–46.
Pirdehghan A, Poortalebi N. Predictors of adherence to type 2 diabetes medication. J Res health Sci. 2016;16(2):72.
PubMed PubMed Central Google Scholar
Aflakseir A. Role of illness and medication perceptions on adherence to medication in a group of Iranian patients with type 2 diabetes. J diabetes. 2012;4(3):243–7.
Iranpour A, Sarmadi V, Allian Mofrad A, Mousavinezhad SA, Mousavinezhad SM, Mohammad Alizadeh F, Neshat S. The Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8): can we trust it? J Diabetes Metabolic Disorders. 2022;21:835–40.
Khanjani Movaghar S, Khazaei S, Borzouei S. Evaluation of medication adherence and its related factors among type 2 diabetic patients. Avicenna J Clin Med. 2021;15(3):158–65.
Soltani R, Eslami AA, Norozi E, Motamedi M. Factors related to treatment adherence in type 2 diabetic people referring to the Tabriz diabetes clinic in 2015: Based on the health belief model. J Health Sci Technol. 2017;10(4):163–9.
Shamsi A, Khodaifar F, Arzaghi SM, Sarvghadi F, Ghazi A. Is there any relationship between medication compliance and affective temperaments in patients with type 2 diabetes? J Diabetes Metabolic Disorders. 2014;13:1–6.
Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH. Adherence to statin therapy in patients with type 2 diabetes: an important dilemma. J Res Med Sci. 2015;1(2):109–14.
Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10(4):933.
CAS PubMed PubMed Central Google Scholar
Khiyali Z, Javidi Z, Elham Banaei E, Afsaneh Ghasemi A, Dehghan A. Relationship between perception of aging and social support with treatment adherence in the aged with type 2 diabetes in Fasa, 2018. J Gerontol. 2021;10(4):54–65.
Tanharo D, Ghods R, Pourrahimi M, Abdi M, Aghaei S, Vali N. Adherence to treatment in diabetic patients and its affecting factors. Pajouhan Sci J. 2018;10(1):37–44.
Fatemi NS, Rafii F, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: a mix method study. Social Determinants Health Supplement. 2018;20(2):179–91.
Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapour-Shahkolaei F. Medication adherence and its related factors in patients with type II diabetes. J Educ Community Health. 2016;30(2):3–12.
Comments (0)